European Pharmaceutical Manufacturer: Were CPHI Frankfurt 2025 expectations met?

European Pharmaceutical Manufacturer asked various leaders in pharma what the highlights of CPHI 2025 were. Abzena’s CCO, Joe Principe, was one of the leaders featured in the roundtable discussion.

1. What did you hope to achieve from your participation at CPHI this year? 

CPHI affords us the opportunity to meet with current and potential clients in a highly focused setting. In addition, we had the opportunity to update our understanding of industry trends, view the competitive landscape and better understand where the pharma services market is headed.

2. Which topics or sessions were you most looking forward to? 

We were keen to see how the competitive landscape on complex biologics, bioconjugates is progressing. There are many geopolitical winds blowing and CPhI gave us an opportunity to better assess the risk and potential rewards resulting from what is happening in our markets.

Click here to access the full article

Didn’t get a chance to meet with our drug development experts at CPHI or World ADC? Contact us today to schedule some time to discuss your program, by visiting: Contact Abzena | Submit Your Inquiry | Abzena